Literature DB >> 426706

Squamous cell carcinoma of the buccal mucosa. A review of 85 cases.

J W Vegers, G B Snow, I van der Waal.   

Abstract

Of 85 cases of squamous cell carcinoma of the buccal mucosa, 61 were treated primarily and 24 secondarily. Sixty-one percent (39) were T3 lesions, and 59% (38) had regional metastases. Nearly half of the patients were more than 70 years of age. Thirty-one percent (19) of the primary patients were treated by surgery alone, 25% (15) by irradiation alone, and 36% (22) by various combinations. The absolute five-year cure rate was 45% for the whole group, and 54% for the primarily and 40% for the secondarily treated patients. For each individual T and N category, the results of surgery were superior over those of radiotherapy. Intra-arterial chemotherapy followed by radiotherapy is to be considered in advanced cases, where composite resection on general grounds is not contemplated. There was a 14% incidence of second primary cancers; these were mainly located in the oral cavity.

Entities:  

Mesh:

Year:  1979        PMID: 426706     DOI: 10.1001/archotol.1979.00790160026006

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  3 in total

Review 1.  Contemporary management of cancer of the oral cavity.

Authors:  Eric M Genden; Alfio Ferlito; Carl E Silver; Robert P Takes; Carlos Suárez; Randall P Owen; Missak Haigentz; Sandro J Stoeckli; Ashok R Shaha; Alexander D Rapidis; Juan Pablo Rodrigo; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

2.  Squamous cell carcinoma of the buccal mucosa involving the masticator space: a case report.

Authors:  Il-Hyung Kim; Hoon Myoung
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-06-28

Review 3.  Is There Still a Place for Brachytherapy in the Modern Treatment of Early-Stage Oral Cancer?

Authors:  Luboš Tuček; Milan Vošmik; Jiří Petera
Journal:  Cancers (Basel)       Date:  2022-01-03       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.